CTB2

Biorepository

IDENTIFYING TB BIOMARKERS, ACCELERATING TREATMENTS

 

​

  • HOME

  • ABOUT CTB2

  • ABOUT THE SAMPLES

  • APPLYING FOR SAMPLES

  • CONTACT

  • More

    PEER REVIEW COMMITTEE

    In order to achieve the goal of distributing the samples from the Biorepository to investigators globally whose later-stage research targets shortening treatment times for TB drugs or identify biomarkers, the CTB2 developed a formal Peer Review Process.  The Peer Review Process will be managed by a Peer Review Committee (PRC), a self-governed Committee which reports to the CTB2 and is dedicated to serving the goals of the Biorepository. 

     

    The PRC includes formal procedures for review of applications for samples from the Biorepository. Current Committee members are listed below.  While members are listed, please direct contact to the Permanent Secretary or the address in the Application Process section.

     

     

    Peer Review Committee Members and Their Affiliations

    Sufian Al Khaldi*, Senior Scientific Advisor, FDA

                                         

    Connie Benson, TB Clinical and Basic Research, ACTG

                                         

    Lei Fang, Biostatistician, Independent

                         

    Jennifer Gardiner*, Biomarker Research,BMGF

                                        

    Judith Giri, Biorepository, Independent

                        

    Daniella Livnat*, Infectious Disease, NIAID

     

    Stephen Murray, TB Clinical and Basic Research, TB Alliance

     

    Payam Nahid, TB Clinical and Basic Research, TBTC

     

    Gerhard Walzl, TB Basic Research, Independent

     

    Frank Weichold, Critical Path and Regulatory Science, FDA

     

    Connie Moreadith*, Permanent Secretary, Independent

     

     

                                                                                               

    Click to learn more about how to obtain samples through Biospecimen Access.

    * Non-voting member

     With Funding From

    U.S. Food and Drug Administration  |  U.S. National Institutes of Allergy and Infectious Diseases  |  Bill & Melinda Gates Foundation

     

    The Consortium for TB Biomarkers Comprises

    Global Alliance for TB Drug Development | TB Trials Consortium | AIDS Clinical Trials Group 

    Contact Us             +1 (646) 616-8637                   tbbiorepository@tballiance.org